New ETF Book by Larry Connors - Click here to read more
(Photo: http://www.newscom.com/cgi-bin/prnh/20090514/NY16746 )
Topical antioxidants can offer cosmetic skin-enhancing benefits when added to a broad spectrum sunscreen. During the course of research, scientists at the COPPERTONE(R) Solar Research Center discovered that not all topical antioxidants are created equal. In addition, the results of independent studies presented by the makers of COPPERTONE at a recent American Academy of Dermatology meeting show that exposure to sunlight can cause some antioxidants to become skin-damaging pro-oxidants. COPPERTONE NutraShield contains specially-selected antioxidants that continue to function even in the presence of UV light. Based upon the results of an ex vivo study, the formula is proven to reduce free radical formation by 74 percent in skin exposed to UV light(1).
In a clinical study conducted by an independent laboratory, results revealed that with daily use on the face, COPPERTONE NutraShield helped reduce visible signs of skin aging and improved skin elasticity, texture and clarity in as little as two weeks in women who showed signs of mild to moderate photo damage (premature skin aging).(1) By the conclusion of the 12-week study, women using NutraShield also experienced, on average, a 20 percent reduction in the appearance of fine lines and wrinkles.(1)
"My patients want to help prevent sun damage and to keep their skin looking youthful," said Dr. Elizabeth Hale, Clinical Associate Professor of Dermatology at the New York University School of Medicine. "To help address these skincare needs, it's convenient to use a broad spectrum, high-SPF sunscreen with antioxidants. I recommend my patients make sun protection a year-round habit to prevent further damage."
A growing body of research reveals that daily sun exposure during everyday activities can contribute to skin damage that appears as fine lines and wrinkles as well as certain types of skin cancer. In response to these findings and consumer demand for multi-benefit skincare products, COPPERTONE developed its NutraShield line -- an SPF 70+ Faces lotion as well as SPF 70+ and SPF 30 lotions for the body -- in lightweight formulas perfect for daily use to help protect and nourish skin.
"COPPERTONE has a legacy of continuous innovation to meet the changing needs of consumers," said Robert Bianchini, PhD, Vice President of R&D, Global Skincare at Schering-Plough Consumer HealthCare. "This year, we're offering consumers powerful broad spectrum sunscreens that also contain what we've discovered to be effective blends of antioxidants to help neutralize free radicals in skin."
(1) Data on file.
About COPPERTONE(R)
COPPERTONE(R), NutraShield(R) and Dual Defense(R) are registered trademarks of Schering-Plough HealthCare Products, Inc.
About Schering-Plough
Schering-Plough Consumer Health Care is the U.S. over-the-counter (OTC) and consumer products business unit of Schering-Plough, an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.
SCHERING-PLOUGH DISCLOSURE NOTICE:
The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to potential market for COPPERTONE(R), NutraShield(R) with Dual Defense(R),. Forward-looking statements relate to expectations or forecasts of future events. Schering-Plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially from Schering-Plough's forward-looking statements, including market forces, economic factors, product availability, patent and other intellectual property protection, current and future branded or generic competition, the regulatory process, and any developments following regulatory approval, among other uncertainties. For further details about these and other factors that may impact the forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including Item 1A. "Risk Factors" in Schering-Plough's First Quarter 2009 10-Q, filed May 1, 2009.
SOURCE Schering-Plough
http://www.schering-plough.com
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
